November 13, 2024
London, UK

November 12, 2024
Ranchos Palo Verdes, USA

November 12, 2024
Boston, USA

November 08, 2024
Zurich, Switzerland

October 29, 2024
Basel, Switzerland

Media release:
English (PDF 0.4 MB) | Deutsch (PDF 0.5 MB)
Interim financial report (PDF 0.6 MB)

Watch the webcast

Download the podcast (MP3 31 MB)

Download the presentation (PDF 6.8 MB)

Novartis Q3 2024 impact and sustainability update (PDF 0.6 MB)

October 28, 2024
Virtual

Download the presentation (PDF 1.4 MB)

Watch the webcast

Download the podcast (MP3 30 MB)

September 26, 2024
Munich, Germany

September 25, 2024
Paris, France

September 18, 2024
London, UK

September 05, 2024
New York, USA

July 18, 2024
Basel, Switzerland

Media release:
English (PDF 0.5 MB) | Deutsch (PDF 0.5 MB) | Français (PDF 0.5 MB)

Interim financial report (PDF 0.5 MB

Watch the webcast

Download the podcast (MP3 34 MB)

Download the presentation (PDF 5.5 MB)

Read the transcript

Novartis Q2 2024 impact and sustainability update (PDF 0.9 MB)

June 27, 2024
Lyon, France

June 20, 2024
London, UK

June 19, 2024
London, UK

June 11, 2024
Miami, USA

June 06, 2024
New York, USA

June 02, 2024
Chicago, USA

Watch the webcast

Download the presentation (PDF 1.0 MB)

Read the media release: Novartis Scemblix® Phase III data first to show superior efficacy with a favorable safety and tolerability profile vs. standard-of-care TKIs in adults with newly diagnosed CML

May 29, 2024
New York, USA

May 23, 2024
Frankfurt, Germany

May 21, 2024
New York, USA

May 20, 2024
Brooklyn, USA

May 15, 2024
Toronto, Canada

May 15, 2024
Las Vegas, USA

April 23, 2024
Basel, Switzerland

Media release:
English (PDF 0.3 MB) | Deutsch (PDF 0.3 MB) | Français (PDF 0.4 MB)

Interim financial report (PDF 0.4 MB)

Watch the webcast

Download the podcast (MP3 30 MB)

Download the presentation (PDF 6.0 MB)

Read the transcript

Novartis Q1 2024 impact and sustainability update (PDF 1.4 MB)

March 26, 2024
Virtual

March 26, 2024
Paris, France

March 21, 2024
Zurich, Switzerland

March 06, 2024
Boston, MA, USA

March 05, 2024
Basel, Switzerland

Visit the General Meetings section

February 28, 2024
London, UK

January 31, 2024
Basel, Switzerland

Media release:
English (PDF 0.3 MB) | Deutsch (PDF 0.3 MB) | Français (PDF 0.3 MB)

Condensed financial report (PDF 0.6 MB)

Watch the webcast

Download the podcast (MP3 34 MB)

Download the presentation (PDF 5.5 MB)

Read the transcript

Novartis Q4 2023 impact and sustainability update (PDF 0.6 MB)

2023 epidemiology data (PDF 1.1 MB)

January 08, 2024
San Francisco, USA 

Watch the webcast

Download the presentation (PDF 1.3 MB)

Download the podcast (MP3 18 MB)

Read the featured news